Innovent Biologics, Inc. A World-Class Biopharmaceutical Company That Develops, Manufactures And Commercializes High-Quality Medicines For The Treatment Of Cancer, Metabolic, Autoimmune, Ophthalmology And Other Major Diseases, Is Pleased To See That The National Medical Products Administration (Nmpa) Of China Has Approved The Supplemental New Drug Application (Snda) For Cyramza
